Pharmacovigilance and Medication Safety Training Course

  • Outline:
  • Pharmacovigilance, also known as drug safety, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problems. Healthcare professionals play a crucial role in preventing Adverse Drug Reactions (ADRs) by recognizing, managing, and reporting ADRs to the national pharmacovigilance centers or the concerned pharmaceutical company of the suspected product. Recognizing ADRs and differentiating them from other diseases or comorbidities is challenging and requires healthcare professionals to know pharmacovigilance and the clinical pharmacological principles of ADRs.

  • This workshop is intended to support the role of healthcare professionals in patient safety through the following:

    • - Be aware of the science of Pharmacovigilance, its scope, and its activities.
    • - Understand the role of spontaneous reporting in achieving public health and safe use of medicines.
    • - Recognize ADRs during daily clinical practice.
    • - Understand the needed information to report ADRs as completely as possible.
    • - Understand the handling of ADR reports.
    •  
  • Who should attend:

    - Community pharmacists
    • - Hospital pharmacists
    • - Clinical pharmacists
    • - Pharmacy and medical students
    • - Nurses
    • - Medication safety officers/pharmacovigilance officers
    • - Patient support specialist
    • - Members of the healthcare team
  •  
  • Instructor(s):
  • - Dr. Hadir Rostom
  • WHO consultant, President of Egypt Chapter of the International Society of Pharmacovigilance (ISoP), Lecturer, Faculty of Pharmacy, MSA University
  •  
  • Duration: 2 days (6 h/day)
  •  
  • Fees: 1000 LE.
  •  
  • Min and max number of attendees:
  • Min: 30
  • Max: 40
  •  
  • Date: 15-16 /11/2023  from 9:00 am to 3:00 pm
  •  
  • Location: Pharmacognosy Department Seminar Room, Third Floor, Faculty of Pharmacy, Ain Shams University.
  •  
  • BOOK NOW